Cargando…

IL‐33/ST2 receptor‐dependent signaling in the development of pulmonary hypertension in Sugen/hypoxia mice

Pulmonary arterial hypertension (PAH) is associated with significant morbidity and mortality. PAH is characterized by pulmonary artery remodeling, elevated right ventricular pressure (RVP) and, ultimately, cardiac failure. Pulmonary endothelial cells can sense danger or damage caused by mechanical i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Indralingam, Cynthia S., Gutierrez‐Gonzalez, Alma K., Johns, Scott C., Tsui, Tzuhan, Cannon, Daniel T., Fuster, Mark M., Bigby, Timothy D., Jennings, Patricia A., Breen, Ellen C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839421/ https://www.ncbi.nlm.nih.gov/pubmed/35150208 http://dx.doi.org/10.14814/phy2.15185

Ejemplares similares

Sugen, hypoxia and the lung circulation
por: Voelkel, Norbert F., et al.
Publicado: (2021)

Transpulmonary amino acid metabolism in the sugen hypoxia model of pulmonary hypertension
por: Philip, Nicolas, et al.
Publicado: (2023)

Increased Eicosanoid Levels in the Sugen/Chronic Hypoxia Model of Severe Pulmonary Hypertension
por: Al-Husseini, Aysar, et al.
Publicado: (2015)

Spatial and temporal resolution of metabolic dysregulation in the Sugen hypoxia model of pulmonary hypertension
por: Simpson, Catherine E., et al.
Publicado: (2023)

Sugen–morphine model of pulmonary arterial hypertension
por: Agarwal, Stuti, et al.
Publicado: (2020)

Emphysema Is—at the Most—Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension
por: Bogaard, Harm J., et al.
Publicado: (2019)

Direct Delivery of MicroRNA96 to the Lungs Reduces Progression of Sugen/Hypoxia-Induced Pulmonary Hypertension in the Rat
por: Docherty, Craig K., et al.
Publicado: (2020)

Using extracellular matrix derived from sugen-chronic hypoxia lung tissue to study pulmonary arterial hypertension
por: Link, Patrick A., et al.
Publicado: (2023)

MicroRNA-212-5p, an anti-proliferative miRNA, attenuates hypoxia and sugen/hypoxia-induced pulmonary hypertension in rodents
por: Chen, Tianji, et al.
Publicado: (2022)

Intratracheal Administration of Prostacyclin Analogue–incorporated Nanoparticles Ameliorates the Development of Monocrotaline and Sugen-Hypoxia-induced Pulmonary Arterial Hypertension
por: Akagi, Satoshi, et al.
Publicado: (2016)

The selective PGI(2) receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats
por: Honda, Yohei, et al.
Publicado: (2020)

Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in Rats
por: Tornling, Göran, et al.
Publicado: (2023)

Isolated heart model demonstrates evidence of contractile and diastolic dysfunction in right ventricles from rats with sugen/hypoxia‐induced pulmonary hypertension
por: Neto‐Neves, Evandro M., et al.
Publicado: (2017)

Reply to Bogaard et al.: Emphysema Is—at the Most—Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension
por: Kojonazarov, Baktybek, et al.
Publicado: (2019)

Understanding longitudinal biventricular structural and functional changes in a pulmonary hypertension Sugen–hypoxia rat model by cardiac magnetic resonance imaging
por: Jayasekera, Geeshath, et al.
Publicado: (2020)

Response to: Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of 3-week Sugen5416/hypoxia mice model?
por: Rodor, Julie, et al.
Publicado: (2023)

Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis
por: Hong, Yeon-Sik, et al.
Publicado: (2011)

The Adult Sprague-Dawley Sugen-Hypoxia Rat Is Still “the One:” A Model of Group 1 Pulmonary Hypertension: Reply to Le Cras and Abman
por: Bogaard, Harm J., et al.
Publicado: (2020)

Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

Shunt-type plexiform lesions identified in the Sugen5416/hypoxia rat model of pulmonary arterial hypertension using synchrotron-based phase-contrast micro-CT
por: van der Have, Oscar, et al.
Publicado: (2022)

Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox
por: Allegra, Alessandro, et al.
Publicado: (2019)

ST2 and IL-33 in Pregnancy and Pre-Eclampsia
por: Granne, Ingrid, et al.
Publicado: (2011)

Role of the IL-33-ST2 axis in sepsis
por: Xu, Hui, et al.
Publicado: (2017)

IL-33/ST2 Axis in Organ Fibrosis
por: Kotsiou, Ourania S., et al.
Publicado: (2018)

The Role of IL-33/ST2 Pathway in Tumorigenesis
por: Larsen, Kristen M., et al.
Publicado: (2018)

The IL-33/ST2 Pathway in Cerebral Malaria
por: Glineur, Corine, et al.
Publicado: (2022)

Integrated systems modeling of severe asthma: Exploration of IL‐33/ST2 antagonism
por: Gadkar, Kapil, et al.
Publicado: (2022)

The IL-33/sST2 Axis in Thromboangiitis Obliterans
por: Sharebiani, Hiva, et al.
Publicado: (2020)

Upregulation of the IL-33/ST2 pathway in dry eye
por: Wang, Shudan, et al.
Publicado: (2019)

Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
por: Cohen, E. Suzanne, et al.
Publicado: (2015)

Critical roles of interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) in pulmonary disorders
por: Xu, Jiao, et al.
Publicado: (2022)

IL-33/ST2 axis in innate and acquired immunity to tumors
por: Jovanovic, Ivan P., et al.
Publicado: (2012)

The Association of Serum IL-33 and sST2 with Breast Cancer
por: Yang, Zhi-Ping, et al.
Publicado: (2015)

Critical Roles of IL-33/ST2 Pathway in Neurological Disorders
por: Abd Rachman Isnadi, Mohammad Faruq, et al.
Publicado: (2018)

IL-33-ST2 Axis in Liver Disease: Progression and Challenge
por: Sun, Zijian, et al.
Publicado: (2017)

Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation
por: Takatori, Hiroaki, et al.
Publicado: (2018)

Emerging Roles of IL-33/ST2 Axis in Renal Diseases
por: Chen, Wei-Yu, et al.
Publicado: (2017)

The Functional Roles of IL-33/ST2 Axis in Ocular Diseases
por: Qian, Yujing, et al.
Publicado: (2020)

The association of serum IL-33/ST2 expression with hepatocellular carcinoma
por: Pan, Xiaolan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_96ppki0uq3mnhpavubd591b7kq